Solid Biosciences (SLDB) just unveiled an announcement.
Adam Koppel and Rajeev Shah resigned from the Board of Directors of Solid Biosciences Inc., effective June 11, 2024, with no disagreements cited regarding the company’s operations. During the Annual Meeting on the same day, stockholders elected four Class III directors and approved several key proposals: the increase of common stock shares available under the 2020 Equity Incentive Plan by 2 million shares, the doubling of authorized company shares to 120 million, and the ratification of PricewaterhouseCoopers LLP as the company’s independent accounting firm for the fiscal year. Additionally, stockholders endorsed the executive compensation approach and recommended annual advisory votes on executive pay.
See more insights into SLDB stock on TipRanks’ Stock Analysis page.
